Head-to-head · WeighScore
EmbraceRX vs HealthOn
The verdict
HealthOn takes it — 59.1/100 to 58.6/100, but only just.
HealthOn grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. HealthOn offers compounded semaglutide and tirzepatide starting at $155/month. EmbraceRX is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | EmbraceRX | HealthOn |
|---|---|---|
| WeighScore | 58.6/100 | 59.1/100 |
| Grade | C | C |
| Scorecard rank | #362 | #349 |
| Semaglutide | Not disclosed | $189/mo (starting dose, 12-month plan, compounded) |
| Tirzepatide | Not disclosed | $290/mo (starting dose, 12-month plan, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #362 · C
Strengths
- Broad compounded GLP-1 menu — semaglutide (+B12), tirzepatide, oral semaglutide/tirzepatide capsules, plus Lipo-B
- Large peptide/longevity catalog (BPC-157, GHK-Cu, NAD+, MOTS-C) across injectable, oral, topical, and nasal formats
- Clinician-guided, compounded at FDA-registered pharmacies; partners with a licensed physician network (Samaritan MD)
- Full legal suite published (Terms, Privacy, HIPAA Notice, CCPA, Returns & Refunds)
Where it loses points
- Pricing not shown upfront — revealed only at checkout after a dose selection
- Offers investigational/research compounds (e.g., retatrutide, AOD-9604) that are not FDA-approved
- Compounding pharmacy partner not named ('FDA-registered pharmacies')
- Not LegitScript-certified (no certification displayed)
Graded #349 · C
Strengths
- Both compounded semaglutide and tirzepatide available
- Weight-loss pricing starts at $189/mo for compounded semaglutide
Where it loses points
- No visible LegitScript certification or PCAB accreditation
- State availability not publicly disclosed
- Lowest advertised prices require a 12-month plan commitment
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.